WO2012093973A3 - Formulations stables d'acarbose - Google Patents

Formulations stables d'acarbose Download PDF

Info

Publication number
WO2012093973A3
WO2012093973A3 PCT/TR2012/000004 TR2012000004W WO2012093973A3 WO 2012093973 A3 WO2012093973 A3 WO 2012093973A3 TR 2012000004 W TR2012000004 W TR 2012000004W WO 2012093973 A3 WO2012093973 A3 WO 2012093973A3
Authority
WO
WIPO (PCT)
Prior art keywords
acarbose
tablets
compositions
formulations
hyperlipoidemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2012/000004
Other languages
English (en)
Other versions
WO2012093973A2 (fr
Inventor
Mahmut Bilgic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2012093973A2 publication Critical patent/WO2012093973A2/fr
Publication of WO2012093973A3 publication Critical patent/WO2012093973A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des formulations contenant de l'acarbose et l'utilisation de ces formulations pour traiter le diabète, l'adiposité et l'hyperlipidémie.
PCT/TR2012/000004 2011-01-06 2012-01-06 Formulations stables d'acarbose Ceased WO2012093973A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2011/00148 2011-01-06
TR2011/00148A TR201100148A2 (tr) 2011-01-06 2011-01-06 Stabil akarboz förmülasyonları.

Publications (2)

Publication Number Publication Date
WO2012093973A2 WO2012093973A2 (fr) 2012-07-12
WO2012093973A3 true WO2012093973A3 (fr) 2012-10-18

Family

ID=45879005

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2012/000004 Ceased WO2012093973A2 (fr) 2011-01-06 2012-01-06 Formulations stables d'acarbose

Country Status (2)

Country Link
TR (1) TR201100148A2 (fr)
WO (1) WO2012093973A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2890370B1 (fr) * 2012-08-31 2019-10-09 The Regents of the University of California Agents utiles pour le traitement de l'obésité, du diabète et de troubles associés
KR101937069B1 (ko) * 2014-12-17 2019-04-03 엠프로스 파마 악티에볼라그 비만 및 관련 대사 장애의 치료를 위한 오를리스타트 및 아카르보스의 변형 방출형 조성물
CN104983771B (zh) * 2015-06-09 2018-12-28 中国科学院西北高原生物研究所 黄刺果实改善脂代谢紊乱的用途
CN104971080B (zh) * 2015-06-09 2018-12-28 中国科学院西北高原生物研究所 黄刺果实多糖改善脂代谢紊乱的用途
CN114053234A (zh) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 一种阿卡波糖片及其制备方法
CN116650430A (zh) * 2023-07-18 2023-08-29 浙江乐普制药有限公司 一种阿卡波糖片及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073428A2 (fr) * 1981-09-01 1983-03-09 Bayer Ag Préparations pharmaceutiques pour des inhibiteurs de glycosidehydrolases
EP0638317A1 (fr) * 1993-08-05 1995-02-15 F. Hoffmann-La Roche Ag Composition pharmaceutique
WO2003055523A1 (fr) * 2001-12-28 2003-07-10 Merck Patent Gmbh Composition pharmaceutique contenant un inhibiteur de la glucosidase-$g(a) ainsi que de l'acide 4-oxobutanoique et son utilisation dans le traitement du diabete
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
CN101019874A (zh) * 2007-03-12 2007-08-22 杭州中美华东制药有限公司 阿卡波糖药物组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347782C3 (de) 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
JPH0739340A (ja) 1993-08-04 1995-02-10 Shozo Shimizu わさび茎葉の高温加熱殺菌による変色防止方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073428A2 (fr) * 1981-09-01 1983-03-09 Bayer Ag Préparations pharmaceutiques pour des inhibiteurs de glycosidehydrolases
EP0638317A1 (fr) * 1993-08-05 1995-02-15 F. Hoffmann-La Roche Ag Composition pharmaceutique
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20080014266A1 (en) * 1998-11-12 2008-01-17 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
WO2003055523A1 (fr) * 2001-12-28 2003-07-10 Merck Patent Gmbh Composition pharmaceutique contenant un inhibiteur de la glucosidase-$g(a) ainsi que de l'acide 4-oxobutanoique et son utilisation dans le traitement du diabete
CN101019874A (zh) * 2007-03-12 2007-08-22 杭州中美华东制药有限公司 阿卡波糖药物组合物及其制备方法

Also Published As

Publication number Publication date
WO2012093973A2 (fr) 2012-07-12
TR201100148A2 (tr) 2012-07-23

Similar Documents

Publication Publication Date Title
IL233154A (en) Compounds, pharmaceuticals containing them and their uses
WO2011130615A3 (fr) Synthèse de lacosamide
IL222268A (en) Preserved pyrollo-pyridines, containing pharmaceutical preparations, combined preparations containing them and their use in the preparation of medicines
IL233200A0 (en) The history of alpha-boronic acid, its preparation and pharmaceutical preparations containing it
IL227625A0 (en) Nanoparticle compounds, their formulations, and their use
ZA201406168B (en) Immunoconjugates, compositions containing them and use
WO2012042371A3 (fr) Composition pharmaceutique
EP2718317A4 (fr) Analogues de polypeptides insulinotropes dépendants du glucose, compositions pharmaceutiques et son utilisation
PL2768937T3 (pl) Preparaty, ich zastosowanie jako środków do mycia naczyń lub do wytwarzania środków do mycia naczyń i ich wytwarzanie
PL2768936T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
IL230463A (en) Benzamides, their preparation and their pharmaceutical preparations
WO2011093824A3 (fr) Formulations effervescentes comprenant du céfaclor
IL227626A0 (en) A compound of 17-il and γ-ifn inhibitors, preparations containing them and their uses
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
HUE037747T2 (hu) Nanostrukturált aprepirant készítmények, eljárások azok elõállítására és az azokat tartalmazó gyógyászati készítmények
WO2011131943A8 (fr) Compositions pharmaceutiques
IL225824A0 (en) History of quinoxaline, their preparation and pharmaceutical preparations containing them
WO2012061480A3 (fr) Compositions et procédés pour l'administration d'agents thérapeutiques
IL229204A (en) Hydroxystilbins that carry paranilations, medicinal preparations and their uses
EP2599490A4 (fr) Compositions antifatigue, son mode de préparation et son utilisation
IL233825A (en) H1-indazole-3-carboxamide compounds, preparations containing them and their use in the preparation of medicines
EP2685993A4 (fr) Compositions pharmaceutiques et utilisation topique de celles-ci
WO2014203275A3 (fr) Procédé amélioré pour la préparation d'apixaban et de ses intermédiaires
ZA201307191B (en) Antiperspirant active compositions and manufacturing thereof
ZA201400646B (en) Topical ophthalmological pharmaceutical composition containing regorafenib

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12710576

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12710576

Country of ref document: EP

Kind code of ref document: A2